1. Home
  2. OM vs FGB Comparison

OM vs FGB Comparison

Compare OM & FGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OM
  • FGB
  • Stock Information
  • Founded
  • OM 2003
  • FGB 2007
  • Country
  • OM United States
  • FGB United States
  • Employees
  • OM N/A
  • FGB N/A
  • Industry
  • OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FGB Finance/Investors Services
  • Sector
  • OM Health Care
  • FGB Finance
  • Exchange
  • OM Nasdaq
  • FGB Nasdaq
  • Market Cap
  • OM 50.5M
  • FGB 60.1M
  • IPO Year
  • OM 2020
  • FGB N/A
  • Fundamental
  • Price
  • OM $11.01
  • FGB $3.85
  • Analyst Decision
  • OM Buy
  • FGB
  • Analyst Count
  • OM 2
  • FGB 0
  • Target Price
  • OM $45.00
  • FGB N/A
  • AVG Volume (30 Days)
  • OM 141.8K
  • FGB 53.0K
  • Earning Date
  • OM 05-07-2025
  • FGB 01-01-0001
  • Dividend Yield
  • OM N/A
  • FGB 8.92%
  • EPS Growth
  • OM N/A
  • FGB N/A
  • EPS
  • OM N/A
  • FGB N/A
  • Revenue
  • OM $113,689,000.00
  • FGB N/A
  • Revenue This Year
  • OM $8.98
  • FGB N/A
  • Revenue Next Year
  • OM $12.74
  • FGB N/A
  • P/E Ratio
  • OM N/A
  • FGB N/A
  • Revenue Growth
  • OM N/A
  • FGB N/A
  • 52 Week Low
  • OM $5.85
  • FGB $2.85
  • 52 Week High
  • OM $78.30
  • FGB $3.74
  • Technical
  • Relative Strength Index (RSI)
  • OM 52.11
  • FGB 40.41
  • Support Level
  • OM $10.30
  • FGB $3.61
  • Resistance Level
  • OM $11.65
  • FGB $3.83
  • Average True Range (ATR)
  • OM 1.20
  • FGB 0.16
  • MACD
  • OM 0.08
  • FGB -0.01
  • Stochastic Oscillator
  • OM 65.42
  • FGB 48.42

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

About FGB First Trust Specialty Finance and Financial Opportunities Fund

First Trust Specialty Fnc & Fncl Oppor is a United States-based closed-end management investment company. The Fund's primary investment objective is to seek a high level of current income. It seeks a positive total return as a secondary objective. The Fund seeks to achieve its investment objectives by investing at least 80% of its Managed Assets in a portfolio of securities of specialty finance and other financial companies.

Share on Social Networks: